Question 1

What are the main end-use segments for Nateglinide, and what share of demand does each represent?

Accepted Answer

Pharmaceutical applications for type 2 diabetes treatment account for around 90% to 95% of demand, mainly through monotherapy and combination therapy, while clinical research applications account for around 5% to 10%.

Question 2

What is the reaction or synthesis route and key intermediates used to manufacture Nateglinide?

Accepted Answer

The process starts with (R)-phenylalanine, which is converted into an N-acyl derivative using acetic anhydride. This intermediate is then coupled with 1,3-benzothiazol-2-ylamine to produce crude nateglinide. The crude product is purified through recrystallisation and chromatography to obtain high-purity API.

Question 3

What are the key intermediate or API cost requirements, and what share of raw material cost do they represent?

Accepted Answer

(R)-Phenylalanine, acetic anhydride, and 1,3-benzothiazol-2-ylamine are the main raw materials and together are estimated to account for around 60% to 75% of total raw material costs.

Question 4

What share of total capital cost do the core reaction and purification equipment represent?

Accepted Answer

Core reaction and purification equipment, including glass-lined and stainless steel reactors, distillation columns, crystallizers, centrifuges, and filter dryers, is estimated to account for around 40% to 50% of total capital cost.

Question 5

What factors drive Nateglinide manufacturing cost the most?

Accepted Answer

The main cost driver is the procurement of high-purity, optically active (R)-phenylalanine. Acetic anhydride and 1,3-benzothiazol-2-ylamine also affect production costs, along with solvent use, purification, utilities, and quality control.

Question 6

What grades or specifications are available for Nateglinide?

Accepted Answer

Nateglinide is available as a high-purity pharmaceutical API that meets applicable regulatory standards and typically appears as a white crystalline powder.

Question 7

What regulatory requirements (FDA, EMA, GMP, DMF filings) apply to Nateglinide manufacturing?

Accepted Answer

Nateglinide manufacturing requires cGMP-compliant facilities, validated processes, quality testing, controlled documentation, and compliance with applicable pharmaceutical standards. FDA, EMA, and DMF requirements may apply depending on the target market and regulatory filing.

Nateglinide Manufacturing Plant Project Report 2026: Cost Analysis, ROI, and Feasibility Insights

About the Author

Vishakha Agrawal

Frequently Asked Questions